The open question is whether policies should lean more heavily on markets, with their proven record of innovation and efficiency, or on government interventions that expand access but risk slowing progress.
getty
Calls to lower drug prices are back…
The open question is whether policies should lean more heavily on markets, with their proven record of innovation and efficiency, or on government interventions that expand access but risk slowing progress.
getty
Calls to lower drug prices are back…